Peptide YY inhibits pancreatic secretion via cholinergic pathways.
The influence of extrapancreatic nerves and intrapancreatic cholinergic activity on the inhibition of pancreatic exocrine secretion by peptide YY (PYY) was studied in conscious dogs. Chronic pancreatic fistulae were created in five mongrel dogs while a second group of five dogs also underwent complete pancreatic denervation. After recovery, a continuous infusion of secretin (62 ng/kg/hr) and cholecystokinin (50 ng/kg/hr) was administered over 2 hr. An infusion of PYY (400 pm/kg/hr) was then given randomly, during either the first or second experimental hour. The experiments were then replicated with a continuous background infusion of (90 micrograms/kg/hr) bethanechol, a cholinergic agonist. The secretin/cholecystokinin-induced bicarbonate and protein outputs were significantly inhibited by PYY in both the innervated and denervated animals. In the denervated animals, bethanechol eliminated the inhibitory effects of PYY. We conclude that extrapancreatic nerves do not mediate the inhibitory effects of PYY. The results suggest that PYY inhibits secretin/cholecystokinin-induced pancreatic response by an intrapancreatic cholinergic mechanism.
Brodish
R J
RJ
Department of Surgery, University of Cincinnati School of Medicine, Ohio 45221.
Kuvshinoff
B W
BW
Fink
A S
AS
McFadden
D W
DW
D000818:Animals; D018723:Bethanechol; D001626:Bethanechol Compounds / Q000494:pharmacology; D001639:Bicarbonates / Q000378:metabolism; D002766:Cholecystokinin / Q000494:pharmacology; D003714:Denervation; D004285:Dogs; D010179:Pancreas / Q000187:drug effects / Q000294:innervation / Q000378:metabolism*; D010275:Parasympathetic Nervous System / Q000502:physiology*; D019894:Peptide YY; D010455:Peptides / Q000494:pharmacology*; D011506:Proteins / Q000378:metabolism; D012633:Secretin / Q000494:pharmacology
D001626:Bethanechol Compounds; D001639:Bicarbonates; D010455:Peptides; D011506:Proteins; D018723:Bethanechol; D019894:Peptide YY; D012633:Secretin; D002766:Cholecystokinin